München
09.11.26 | 12:56
0,339 Euro
+16,72 % +0,049
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,306 | 0,335 | 09.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Senzime Expands TetraGraph's Clinical Use Beyond Surgery Into Brain Stimulation Therapy | 452 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / November 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the expanded clinical use of its... ► Artikel lesen | |
| Do | Senzime AB: Senzime Expands TetraGraph's Clinical Use Beyond Surgery into Brain Stimulation Therapy | 258 | GlobeNewswire (Europe) | UPPSALA, Sweden - Senzime AB (publ), a global leader in precision-based patient monitoring, today announced the expanded clinical use of its TetraGraph® system in electroconvulsive therapy (ECT), a... ► Artikel lesen | |
| 29.10. | Senzime reiterates positive cash flow in Q4 as sensors grow 43% and gross margin reaches 74% | 1 | Seeking Alpha | ||
| 29.10. | Senzime AB Q3 Loss Drops | 1 | RTTNews | ||
| 29.10. | Senzime Q3 2026: Continued Strong Sensor Sales and Growth in All Segions. Clear Progress Towards Profitability | 370 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for July - September (Q3) 2026 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 29.10. | Senzime AB: Senzime Q3 2026: Continued strong sensor sales and growth in all regions. Clear progress towards profitability. | 127 | GlobeNewswire (Europe) | Senzime AB's (publ) interim report for July - September (Q3) 2026 is now available on the company's website www.senzime.com.
Financial information Q3 2026:Net sales amounted to TSEK 30,099 (26,478)... ► Artikel lesen | |
| SENZIME Aktie jetzt für 0€ handeln | |||||
| 26.10. | Invitation to Presentations of Senzime's Third Quarter 2026 Report | 276 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 26, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to presentations of the third quarter report for 2026 on Oct 29. The... ► Artikel lesen | |
| 17.10. | New Scientific Evidence Presented at ANESTHESIOLOGY 2026 Strengthens the Case for Senzime's TetraGraph and Quantitative Neuromuscular Monitoring | 930 | ACCESS Newswire | UPPSALA, SE AND SAN DIEGO, CA / ACCESS Newswire / October 17, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) Senzime AB (publ), a global leader in precision-based patient monitoring solutions, today announced... ► Artikel lesen | |
| 13.10. | Senzime Launches Industry-First Predictive Neuromuscular Monitoring Technology | 272 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 13, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ), a global leader in precision-based patient monitoring solutions, today announced the upcoming... ► Artikel lesen | |
| 05.10. | Senzime Reaffirms Its Target of Reaching Positive Cash Flow Within Q4 2026 | 369 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 5, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - "We reaffirm our target of reaching positive cash flow within the fourth quarter of 2026, despite seeing challenges... ► Artikel lesen | |
| 28.09. | Senzime Strengthens Financing to Support Strategic OEM Expansion and Path to Profitability | 603 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 28, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has strengthened its financing structure through a new SEK 35 million non-dilutive... ► Artikel lesen | |
| 28.09. | Senzime AB: Senzime strengthens financing to support strategic OEM expansion and path to profitability | 336 | GlobeNewswire (Europe) | Uppsala, Sweden - Senzime AB today announced that it has strengthened its financing structure through a new SEK 35 million non-dilutive credit facility with a group of institutional investors, including... ► Artikel lesen | |
| 24.09. | Senzime Secures Additional Major US Hospital Network Contract, Expanding Adoption of its Next-generation Neuromuscular Monitoring Technology | 476 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 24, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another contract with a leading multi-hospital academic health system based... ► Artikel lesen | |
| 05.08. | Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed | 505 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / August 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a leader in precision-based perioperative monitoring solutions, today announced that the U.S. Department of... ► Artikel lesen | |
| 16.07. | Senzime AB (publ) reports Q2 results | 1 | Seeking Alpha | ||
| 16.07. | Senzime: Interim Report Q2 2026: Strong Sensor Sales and Improved Margins, Despite Continued U.S. Monitor Market Headwinds | 749 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 16, 2026 / Senzime AB's (publ) (STO:SEZI)(OTCQX:SNZZF) interim report for April - June (Q2) 2026 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 15.07. | Senzime and Philips Medical Systems Enter Development and Commercialization Partnership | 571 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 15, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB announced today that it has entered into a long-term agreement with Philips Electronics Nederland, B.V. through... ► Artikel lesen | |
| 13.07. | Invitation to Presentations of Senzime's Second Quarter 2026 Report | 394 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 13, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to presentations of the second quarter report for 2026 on July 16. The report will... ► Artikel lesen | |
| 29.06. | Senzime's TetraGraph System Receives ANVISA Regulatory Approval in Brazil | 419 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) announced today that the TetraGraph system has received approval from the Brazilian Health Regulatory Agency (ANVISA)... ► Artikel lesen | |
| 05.06. | Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026 | 397 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 5, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the launch of TetraAnalytics, a new data analytics... ► Artikel lesen |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 33,980 | -2,80 % | 0,60 Dioptrien weniger Fortschreiten: Warum ZEISS bei Kinderbrillen auf dynamische Signale setzt | ||
| ECKERT & ZIEGLER | 13,830 | +0,22 % | Eckert&Ziegler: 23 Euro Kursziel und die Frage nach dem nächsten Schub | ||
| INTUITIVE SURGICAL | 412,45 | +1,51 % | ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue? | ||
| UNITEDHEALTH | 354,60 | +0,23 % | UnitedHealth Group adds former CHOP CEO to board | ||
| DRAEGERWERK | 101,80 | -1,36 % | Carl Zeiss Meditec hängt Drägerwerk und Sartorius ab: Unterschiedliche Impulse | ||
| GERRESHEIMER | 31,000 | -0,64 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| THERMO FISHER | 636,00 | +1,99 % | Thermo Fisher Scientific: 5-Milliarden-Rückkauf, aber die Aktie fällt - der Haken | ||
| TELADOC HEALTH | 8,168 | +3,94 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| ESSILORLUXOTTICA | 192,35 | -0,62 % | Erben blockieren Mega-Deal: Machtkampf um 43 Milliarden Euro: Droht EssilorLuxottica ein Beben? | © Foto: SOPA Images - Sipa USAEin Erbstreit um 43 Milliarden Euro erschüttert das Ray-Ban-Imperium. Vier Erben blockieren einen Milliardendeal. Bei EssilorLuxottica wächst die Unsicherheit Enthaltene... ► Artikel lesen | |
| HIMS & HERS HEALTH | 20,840 | -10,71 % | Neuer Vertriebskanal: Der nächste Coup im Abnehm-Markt? Eli Lilly überrascht mit diesem Deal | © Foto: Sascha Lotz/dpaEli Lilly geht eine ungewöhnliche Partnerschaft ein. Das steckt hinter dem neuen Vertriebsweg für seine Abnehmmedikamente Enthaltene Werte: US5324571083,US4330001060Den vollständigen... ► Artikel lesen | |
| FAMICORD | 2,430 | -5,45 % | EQS-Adhoc: FamiCord AG: FamiCord beschließt Bezugspreis und Anzahl neuer Aktien für beabsichtigte Bezugsrechtskapitalerhöhung | EQS-Ad-hoc: FamiCord AG / Schlagwort(e): Kapitalmaßnahmen / Kapitalerhöhung
FamiCord AG: FamiCord beschließt Bezugspreis und Anzahl neuer Aktien für beabsichtigte Bezugsrechtskapitalerhöhung... ► Artikel lesen | |
| M1 KLINIKEN | 18,780 | -1,47 % | Drohnenauftrag für Volatus, KI-Strom treibt Infineon und Beauty-Boom bei M1 Kliniken: Drei spannende Aktien im Check | Drohnen fürs kanadische Militär, Chips für den KI-Boom und Schönheitsbehandlungen mit satten Margen: Börsenfantasie hat viele Gesichter. Volatus Aerospace könnte mit einem kanadischen Militärauftrag... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 39,335 | +2,52 % | 3 Funktionen, die Patienten zurückwollen: Was Coloplasts, Boston Scientifics und NurExones Tierdaten zeigen | ||
| DEXCOM | 72,00 | +0,84 % | DexCom: Starke Zahlen, aber die Aktie bleibt unter Druck - was die Prognose jetzt bringt | ||
| ALIGN TECHNOLOGY | 155,55 | +4,36 % | Align Technology Launches $270 Mln Accelerated Stock Repurchase Agreement |
SENZIME AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,339 Euro und damit +16,72 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SENZIME AB finden Sie auf Wallstreet Online.